TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics is a fully integrated, next-generation TCR-T cell therapy company. Founded in 2018, TScan’s platform was developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and Harvard Medical School. TScan’s transformative platform enables rapid discovery of TCRs and targets for engineered T cell therapy. This technology is extremely versatile and is applicable across multiple therapeutic areas beyond cancers, including autoimmune disorders and infectious diseases.
Company Details
- Employees
- 206
- Founded
- -
- Address
- 830 Winter St, Waltham,massachusetts 02451,united States
- Phone
- 857-399-9500
- in****@****can.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.tscan.com/
- Keywords
- TCR-T Cell Therapy.
- HQ
- Waltham, Massachusetts
Tscan Therapeutics Questions
Tscan Therapeutics's helpline number is 857-399-9500
Tscan Therapeutics's website is https://www.tscan.com/
Tscan Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tscan-therapeutics
Tscan Therapeutics has
206 employees.
View email and phone details for 206
employees at Tscan Therapeutics.
Tscan Therapeutics's industry is
Biotechnology Research
Tscan Therapeutics's top competitors are
Kymera Therapeutics,
Vertex Pharmaceuticals,
Be Biopharma,
Tessera Therapeutics,
Verve Therapeutics,
Bonito Biosciences,
Immunitas Therapeutics,
Beam Therapeutics,
Sarepta Therapeutics,
Vor Bio.
Tscan Therapeutics's support email address is info@tscan.com
Tscan Therapeutics's categories are Biotechnology Research
Tscan Therapeutics's founding year is 2018
